Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 270 participants.
Also called NCT06704672
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 270 participants
- Registry
-
NCT06704672
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Poland, Türkiye
- Registry status
- Recruiting
Technical summary
Registry record NCT06704672. Randomized; no masking; primary purpose diagnostic. Start 2025-04-14 (actual); primary completion 2026-11-15 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus
- Condition
- Type 1 Diabetes Mellitus
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Device)
- Accu-Chek SmartGuide CGM Solution
- Intervention (Device)
- Accu-Chek SmartGuide Sensor and Blinded Apps
- Intervention (Device)
- SMBG Device
- Lead sponsor
- Hoffmann-La Roche
- Collaborator
- Roche Diabetes Care
Record details
- Record id
cardio:ct-nct06704672- Content hash
d8b538c71db36ff5510aab74d9feb6bf9b57eaf3ba6680a6dfea41d56c44ca1f